Encompass Health CorporationEHCNYSE
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +11.94% | +12.69% | +10.59% | +12.03% | +9.36% |
| Gross Profit Growth | +12.92% | +14.46% | +15.57% | +15.43% | +24.07% |
| EBITDA Growth | +20.43% | +20.15% | +23.14% | +18.38% | +12.12% |
| Operating Income Growth | -51.42% | -47.77% | +28.67% | +20.18% | +16.50% |
| Net Income Growth | +26.85% | +38.01% | +34.67% | +24.54% | +16.91% |
| EPS Growth | +25.58% | +36.36% | +33.93% | +24.78% | +16.67% |
| EPS Diluted Growth | +26.19% | +37.21% | +34.55% | +24.11% | +16.98% |
| Weighted Average Shares Growth | +0.40% | +0.50% | +0.70% | +0.70% | +0.60% |
| Weighted Average Shares Diluted Growth | +0.69% | +0.79% | -0.10% | +0.20% | +0.20% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +24.44% | +38.71% | +20.85% | +24.29% | +1.12% |
| Free Cash Flow Growth | +75.62% | +0.00% | +26.26% | +87.27% | -30.42% |
| Receivables Growth | +7.56% | -2.09% | +0.66% | +3.87% | +5.97% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +8.28% | +7.08% | +6.58% | +6.21% | +6.31% |
| Book Value per Share Growth | +25.09% | +24.84% | +23.09% | +23.10% | +20.40% |
| Debt Growth | -4.30% | -7.47% | -7.42% | -8.81% | -4.93% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +6.88% | +3.13% | +4.67% | +14.53% | -17.98% |